The α2 helix in the DNA ligase IV BRCT-1 domain is required for targeted degradation of ligase IV during adenovirus infection

Timra Gilson, Amy E. Greer, Alessandro Vindigni, Gary Ketner, Leslyn A. Hanakahi

Research output: Contribution to journalArticle

Abstract

In adenovirus E4 mutant infections, viral DNAs form concatemers through a process that requires host Non-homologous End Joining (NHEJ) proteins including DNA Ligase IV (LigIV). Adenovirus proteins E4 34k and E1b 55k form the substrate-selection component of an E3 ubiquitin ligase and prevent concatenation by targeting LigIV for proteasomal degradation. The mechanisms and sites involved in targeting this and other E3 ligase substrates generally are poorly-understood. Through genetic analysis, we identified the α2 helix of one LigIV BRCT domain (BRCT-1) as essential for adenovirus-mediated degradation. Replacement of the BRCT domain of DNA ligase III (LigIII), which is resistant to degradation, with LigIV BRCT-1 does not promote degradation. A humanized mouse LigIV that possesses a BRCT-1 α2 helix identical to the human protein, like its parent, is also resistant to adenovirus-mediated degradation. Thus, both the BRCT-1 α2 helix and an element outside BRCT-1 are required for adenovirus-mediated degradation of LigIV.

Original languageEnglish (US)
Pages (from-to)128-135
Number of pages8
JournalVirology
Volume428
Issue number2
DOIs
StatePublished - Jul 5 2012

Keywords

  • Adenovirus
  • DNA Ligase IV
  • NHEJ
  • Substrate selection
  • Ubiquitin ligase

ASJC Scopus subject areas

  • Virology

Fingerprint Dive into the research topics of 'The α2 helix in the DNA ligase IV BRCT-1 domain is required for targeted degradation of ligase IV during adenovirus infection'. Together they form a unique fingerprint.

  • Cite this